Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
News
15 Aug 2024
CMS reaches agreements for lower prices of 10 drugs
The negotiated prices mark a 38–79% discount off of list prices that could save roughly $6 billion annually. Continue Reading
By- Veronica Salib, Assistant Editor
-
Feature
12 Aug 2024
Exploring trends shaping the future of specialty pharmacy
The pharmacy industry is evolving with specialty drugs, requiring advanced management and technology solutions to control costs and improve patient outcomes. Continue Reading
-
News
22 Feb 2022
FDA Grants Emergency Authorization For Eli Lilly’s COVID-19 Antibody
In other COVID news, WHO grants Roche’s Actemra prequalification for COVID-19 in adults and Gilead’s COVID-19 treatment was well tolerated in pediatric patients. Continue Reading
By- Samantha McGrail
-
News
17 Feb 2022
Bristol Myers Grants $7.9M to Improve Access to Care Across US
The health equity grants will increase access to care and support diversity, cultural competency, and collaboration among community health workers across the US. Continue Reading
By- Samantha McGrail
-
News
09 Feb 2022
FDA Approves Takeda’s Von Willebrand Disease Treatment
Other recent FDA Approvals include a T-cell receptor for adults with unresectable or metastatic uveal melanoma and insomnia treatment. Continue Reading
By- Samantha McGrail
-
News
07 Feb 2022
CHMP Issues Positive Opinion of Pfizer’s COVID-19 Treatment
In other COVID news, Novavax and Israel entered into an agreement to supply Novavax’s COVID-19 vaccine in Israel and Daiichi Sankyo initiates a trial to study its vaccine booster in Japan. Continue Reading
By- Samantha McGrail
-
News
03 Feb 2022
FDA Approves Label Update for CAR-T Cell Therapy, Yescarta
Yescarta is now the first and only chimeric antigen receptor (CAR) T-cell therapy with information on the label to help treat patients with large B-cell lymphoma. Continue Reading
By- Samantha McGrail
-
News
02 Feb 2022
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine
In other COVID news, Novavax submits an emergency use authorization request to FDA for its COVID-19 vaccine and Merck’s COVID-19 treatment is proven effective against Omicron. Continue Reading
By- Samantha McGrail
-
News
01 Feb 2022
Eli Lilly Invests $1B in Facility to Boost Access to Medicine in NC
The facility will utilize the latest technology to manufacture Eli Lilly and Company’s injectable products to increase access to medicine in North Carolina. Continue Reading
By- Samantha McGrail
-
News
28 Jan 2022
2020 Drug Price Increase Driven by Generic Drugs, Biosimilars
The Vizient 2022 Pharmacy Market Outlook found that the overall estimated drug price inflation rate will be 3.09% due to high-cost medications, generic drugs to market, and biosimilars. Continue Reading
By- Samantha McGrail
-
News
27 Jan 2022
FDA Expedites Approval of Gilead’s COVID-19 Treatment, Remdesivir
In other COVID news, FDA revises the authorization for two monoclonal antibody treatments and Pfizer initiates a clinical trial to study a new Omicron-based vaccine candidate. Continue Reading
By- Samantha McGrail
-
News
27 Jan 2022
FDA Grants Clearance to Biotricity’s Arrhythmia Monitoring Device
The device addresses the current limitation of existing Holter monitors and creates a revenue stream with a simplified workflow to lower turnaround time and risk for patients and providers. Continue Reading
By- Samantha McGrail
-
News
24 Jan 2022
Cosette Acquires 8 Prescription Medications from Daiichi Sankyo
The transaction adds eight prescription medications focused on cardiovascular indications to Cosette Pharma’s current portfolio of over 45 commercial products. Continue Reading
By- Samantha McGrail
-
News
07 Jan 2022
Big Pharma Cooperation Advances Digital Measures, Drug Development
Industry cooperation to boost digital measures and focus on a more “patient-first” approach helps bring effective drugs to market for patients more quickly. Continue Reading
By- Samantha McGrail
-
News
06 Jan 2022
FDA Expands MRI Compatibility for XR Spinal Cord Stimulation
FDA’s new labeling lifts MRI restrictions for lead tip locations and radiofrequency power used as part of the standard operating mode of an MRI scan. Continue Reading
By- Samantha McGrail
-
News
06 Jan 2022
FDA Authorizes Siemens Healthineers COVID-19 Antigen Self-Test
In a recent study, the CLINITEST Rapid COVID-19 Antigen Self-Test demonstrated sensitivity of 86.5% and a specificity of 99.3% compared to the PCR detection method. Continue Reading
By- Samantha McGrail
-
News
05 Jan 2022
FDA Approves Two Pediatric Indications For J&J’s Xarelto
Xarelto now has 11 indications in the US, the most of any direct oral anticoagulant (DOAC), and is the most studied oral FactorXa inhibitor in its class. Continue Reading
By- Samantha McGrail
-
News
04 Jan 2022
FDA Expands Authorization for Pfizer’s COVID-19 Vaccine Booster
FDA amended the authorization for the COVID-19 vaccine booster to include children 12 and older two months after expanding the authorization to include individuals 18 years and older. Continue Reading
By- Samantha McGrail
-
News
03 Jan 2022
Biogen to Reduce Price of Alzheimer’s Disease Treatment by 50%
For a patient of average weight, the annual cost at the maintenance dose of the Alzheimer’s disease treatment will be $28,200. Continue Reading
By- Samantha McGrail
-
News
23 Dec 2021
FDA Approves ViiV Healthcare’s Long-Acting Injectable for HIV
In addition to ViiV’s long-acting injectable to treat HIV, recent FDA approvals include a myasthenia gravis treatment and AstraZeneca and Amgen’s asthma treatment. Continue Reading
By- Samantha McGrail
-
News
22 Dec 2021
FDA Approves Pfizer’s Drug to Treat Adult Patients With AS
FDA approves Pfizer’s tofacitinib for AS patients. The drug is the first and only oral JAK inhibitor approved in the US for five indications. Continue Reading
By- Samantha McGrail
-
News
17 Dec 2021
CHMP Issues Positive Opinion of J&J’s COVID-19 Vaccine Booster
In other COVID news, Pfizer re-confirms the efficacy of its COVID-19 vaccine booster shot and GSK and Sanofi’s COVID-19 booster elicits strong immune responses in a clinical trial. Continue Reading
By- Samantha McGrail
-
News
08 Dec 2021
FDA Approves Imaging Drug to Identify Ovarian Cancer
FDA approves Cytalux to improve the ability to locate additional ovarian cancerous tissue that is generally difficult to detect. Continue Reading
By- Samantha McGrail
-
News
06 Dec 2021
CVS Health Initiatives Increase Affordability, Access To Medicine
CVS Health announces several steps to support its strategy to make healthcare more convenient, affordable, and accessible. Continue Reading
By- Samantha McGrail
-
News
02 Dec 2021
FDA Addresses Impacts of New Variant, Urges COVID-19 Vaccinations
FDA is actively evaluating the potential impacts of the new COVID variant on currently available vaccines and urges COVID-19 vaccinations or booster shots. Continue Reading
By- Samantha McGrail
-
News
29 Nov 2021
FDA Approves First Treatment for Children with Achondroplasia
In a Phase 3 study, patients receiving the achondroplasia drug grew an average of 1.57 centimeters taller than those receiving a placebo. Continue Reading
By- Samantha McGrail
-
News
29 Nov 2021
CVS, Walgreens & Walmart Helped Fuel Opioid Crisis in Ohio Counties
The Ohio counties blamed CVS, Walgreens, and Walmart for not doing enough to stop the flow of prescription pills that caused an opioid crisis and cost each county about $1B. Continue Reading
By- Samantha McGrail
-
News
23 Nov 2021
CDC Expands COVID-19 Vaccine Booster Shots To All Americans
The CDC stated that all Americans 18 years and older who have completed the primary series “should” get a COVID-19 vaccine booster shot of an FDA authorized vaccine. Continue Reading
By- Samantha McGrail
-
News
22 Nov 2021
FDA Grants Designation For Early-Stage Breast Cancer Blood Test
In previous studies, Datar Cancer Genetics’ blood test detected Stage 0 and Stage 1 breast cancers with high accuracy. Continue Reading
By- Samantha McGrail
-
News
19 Nov 2021
FDA Expands Pfizer’s COVID-19 Vaccine Booster Authorization
FDA expands emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine booster shot to include individuals 18 years of age and older. Continue Reading
By- Samantha McGrail
-
News
19 Nov 2021
FDA Approves Rare Blood Disease Injection For Adults
Two individual studies found that after 7.5 years of treatment with Besremi 61% of patients with the rare blood disease polycythemia vera saw a complete hematological response. Continue Reading
By- Samantha McGrail
-
News
15 Nov 2021
Abbott, ADA Initiative Addresses Diabetes Care Management in POC
This is the first initiative under the ADA’s Health Equity Now platform to address diabetes care management in people of color. The program will launch in Columbus, Ohio. Continue Reading
By- Samantha McGrail
-
News
12 Nov 2021
CHMP Recommends Approval Of Roche’s COVID-19 Antibody Combination
The committee recommends the approval of Roche’s COVID-19 antibody combination based on positive data from Phase 3 trials, which found that the drug reduced risk of death by 20%. Continue Reading
By- Samantha McGrail
-
News
08 Nov 2021
FDA Approves Novartis’ Chronic Myeloid Leukemia Treatment
Novartis’ Scemblix is the first FDA-approved chronic myeloid leukemia treatment that binds to the ABL myristoyl pocket. Continue Reading
By- Samantha McGrail
-
News
08 Nov 2021
CDC Recommends Pfizer- BioNTech COVID-19 Vaccine for Children
The CDC expands COVID-19 vaccine recommendations to nearly 28 million children for children five to 11 years of age in the US. Continue Reading
By- Samantha McGrail
-
News
02 Nov 2021
FDA Authorizes Thermo Fisher’s COVID-19 New Test Collection Method
Thermo Fisher can now run COVID-19 tests from saliva samples collected with the Spectrum Solutions SpectrumDNA SDNA-1000 collection device on the Amplitude Solution. Continue Reading
By- Samantha McGrail
-
News
01 Nov 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children
FDA based its decision on a Phase 2/3 trial that found two doses of the Pfizer-BioNTech COVID-19 vaccine to 90.7% effective in preventing COVID-19 in children aged five to 11. Continue Reading
By- Samantha McGrail
-
News
28 Oct 2021
FDA Accepts Application for Novartis’ Diabetic Macular Edema Drug
FDA based its decision on the KITE and KESTREL trials, which studied Novartis’ diabetic macular edema drug in 926 patients in 36 countries. Both trials met their primary endpoint. Continue Reading
By- Samantha McGrail
-
News
25 Oct 2021
FDA Approves Expansion of Gilead’s HIV Drug in Pediatric Patients
FDA approves a new low-dose tablet dosage form of Gilead’s HIV drug for younger children living with the disease. Continue Reading
By- Samantha McGrail
-
News
22 Oct 2021
CDC Unanimously Recommends J&J, Moderna COVID-19 Vaccine Booster
CDC unanimously recommends a booster dose of the Johnson & Johnson and Moderna COVID-19 vaccines one day after FDA approval. Continue Reading
By- Samantha McGrail
-
Answer
22 Oct 2021
CVS Health Says Pharmacists Key for Medication Adherence, Access
CVS Health works to empower pharmacists to become more involved in patient care, including boosting medication adherence, allowing for a more personalized and proactive approach to care. Continue Reading
By- Samantha McGrail
-
News
21 Oct 2021
FDA Authorizes Moderna, J&J Booster COVID-19 Vaccine Dose
FDA grants emergency use authorization for both Moderna and Johnson & Johnson’s COVID-19 vaccine booster doses based on the totality of scientific evidence. Continue Reading
By- Samantha McGrail
-
News
21 Oct 2021
FDA Approves Interchangeable Biosimilar for Inflammatory Diseases
The approval is the second interchangeable product that FDA has approved and the first interchangeable biosimilar to treat certain inflammatory diseases. Continue Reading
By- Samantha McGrail
-
News
20 Oct 2021
FDA Approves First Treatment for Rare Disease Congenital Athymia
FDA based its approval on clinical studies, which found that the rare disease drug significantly improved survival of children with congenital athymia. Continue Reading
By- Samantha McGrail
-
News
12 Oct 2021
FDA Grants Designation For Daiichi Sankyo’s Breast Cancer Treatment
FDA granted the designation based on data from a Phase 3 trial in which Enhertu reduced the risk of disease progression or death in HER2 positive breast cancer patients by 72%. Continue Reading
By- Samantha McGrail
-
News
07 Oct 2021
FDA Approves Kite’s CAR T-Cell Therapy For Leukemia
Other recent FDA approvals include a rare liver disease drug for pruritus and AbbVie’s episodic migraine drug. Continue Reading
By- Samantha McGrail
-
News
06 Oct 2021
FDA Approves Amgen’s Repatha for Autosomal Dominant Disease
FDA approved Repatha for pediatric patients with autosomal dominant disease, heterozygous familial hypercholesterolemia, as an adjunct to diet and other LDL-C lowering therapies. Continue Reading
By- Samantha McGrail
-
News
30 Sep 2021
Eli Lilly and Company to Drop Insulin Costs 40% in the US
The new list price of the company’s insulin, effective January 2022, will be $82.41 for individual vials and $159.12 for a pack of five pens. Continue Reading
By- Samantha McGrail
-
News
24 Sep 2021
COVID-19 Treatment Remdesivir Reduces Hospitalizations by 87%
In other COVID news, Canada approves Moderna’s COVID-19 vaccine and Pfizer and BioNTech will supply more vaccine doses to the US for donation to low-and lower-middle-income countries. Continue Reading
By- Samantha McGrail
-
News
09 Sep 2021
FDA Approves Johnson & Johnson’s Schizophrenia Injectable
Other recent FDA approvals include Merck’s Keytruda for bladder cancer and BeiGene’s Brukinsa to treat adult patients with Waldenström’s macroglobulinemia. Continue Reading
By- Samantha McGrail
-
News
02 Sep 2021
AMA, APhA, ASHP Call for Immediate End to Ivermectin for COVID-19
The organizations urged physicians, pharmacists, and other prescribers to warn patients against the use of ivermectin outside of FDA-approved indications and guidance. Continue Reading
By- Samantha McGrail
-
News
02 Sep 2021
FDA Approves Vivistim System for Chronic Ischemic Stroke
Other FDA approvals include an injection to treat pediatric patients with growth failure and an injection to treat moderate to severe pruritus associated with chronic kidney disease. Continue Reading
By- Samantha McGrail
-
News
18 Aug 2021
FDA Approves New Indication for Chronic Disease Treatment
The chronic disease treatment, Xywav, is approved to treat cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. Continue Reading
By- Samantha McGrail
-
News
12 Aug 2021
FDA Accepts Merck’s Keytruda Application for Endometrial Carcinoma
Merck based its application on overall response data from the KEYNOTE-158 trial, evaluating Keytruda in various types of advanced solid tumors, including endometrial carcinoma. Continue Reading
By- Samantha McGrail
-
News
09 Aug 2021
FDA Broadens Authorization for Eli Lilly’s COVID-19 Treatment
In other COVID news, AstraZeneca’s COVID-19 vaccine and an mRNA vaccine were similar in a real-world study, and GSK and Vir will supply the EU with 22,000 doses of their COVID-19 treatment. Continue Reading
By- Samantha McGrail
-
News
06 Aug 2021
FDA Approves GSK’s Antibody for Chronic Disease Management
Other recent FDA approvals include J&J’s pulmonary arterial hypertension therapy and an expanded label approval for AbbVie’s BOTOX for upper limb spasticity in adults. Continue Reading
By- Samantha McGrail
-
News
29 Jul 2021
AstraZeneca’s COVID-19 Vaccine 82% Effective Against Variants
In other COVID news, the US purchased an additional 200M doses of the Pfizer-BioNTech COVID-19 vaccine while Japan will purchase an additional 50M doses of Moderna’s vaccine. Continue Reading
By- Samantha McGrail
-
News
28 Jul 2021
FDA Approves Merck’s Keytruda Treatment for Endometrial Carcinoma
Other FDA approvals include AstraZeneca’s type 2 diabetes treatment, a rare genetic disorder treatment, and AbbVie’s treatment for acute bacterial skin and skin structure infections. Continue Reading
By- Samantha McGrail
-
News
27 Jul 2021
Bristol Myers Squibb Pulls Immunotherapy Opdivo from US Market
The move follows the FDA Advisory Committee’s evaluation of accelerated approvals for checkpoint inhibitors that did not meet their post-marketing requirements. Continue Reading
By- Samantha McGrail
-
News
22 Jul 2021
FDA Approves Sanofi’s All-Oral Treatment for Sleeping Sickness
Other FDA approvals include a treatment for adult and pediatric patients with chronic graft-versus-host disease and tablets for complications associated with chronic kidney disease. Continue Reading
By- Samantha McGrail
-
News
09 Jul 2021
FDA: Aduhelm Only to Be Given to Early-Stage Alzheimer’s Patients
FDA has reversed its broad approval for the Alzheimer’s drug after the first 87-year-old patient who received the medication in Chicago saw disease progression. Continue Reading
By- Samantha McGrail
-
News
06 Jul 2021
FDA Approves Key Component for Common Childhood Cancer Treatment
Other recent FDA approvals include Direct Biologics Phase 1/2 trial application for its COVID-19 treatment and Angel Medical Systems cardiac detection monitor for ACS patients. Continue Reading
By- Samantha McGrail
-
News
24 Jun 2021
FDA Approves Boehringer’s Pediatric Oral Blood Thinner
Other recent FDA approvals include an edema drug for patients with heart failure, a systemic mastocytosis treatment, and a nasal antihistamine for allergic rhinitis. Continue Reading
By- Samantha McGrail
-
News
22 Jun 2021
Aduhelm to Boost Prescription Drug Spending Over $73B by 2028
By mid 2020, Biogen’s Alzheimer’s drug, Aduhelm, may constitute more than 1% of all national healthcare spending and increase total prescription drug spending by over 8%. Continue Reading
By- Samantha McGrail
-
News
21 Jun 2021
CRISPR Therapeutics, Capsida Collaborate to Develop Gene Therapies
The companies will leverage adeno-associated virus vectors to develop gene therapies for the treatment of ALS and Friedreich’s ataxia. Continue Reading
By- Samantha McGrail
-
News
18 Jun 2021
Biden Invests Over $3B to Boost COVID-19 Antiviral Development
The initiative, called the Antiviral Program for Pandemics, is part of the Biden Administration’s whole-of-government strategy to develop the next generation of COVID-19 antiviral medicines. Continue Reading
By- Samantha McGrail
-
News
15 Jun 2021
FDA Approves Novo Nordisk’s Obesity Drug Wegovy
In addition to the obesity drug, FDA approves the first treatment for patients with plasminogen deficiency type 1 and Chimerix Inc’s Tembexa to treat smallpox. Continue Reading
By- Samantha McGrail
-
News
14 Jun 2021
3 FDA Committee Members Resign Over Alzheimer’s Drug Approval
Following the approval of Biogen’s Alzheimer’s drug last week, 3 FDA advisory committee members have resigned after FDA ignored their input during the decision-making process. Continue Reading
By- Samantha McGrail
-
News
08 Jun 2021
Abbott, Walgreens Increase Rapid COVID-19 Testing in Pennsylvania
Under a new pilot program, each Philadelphia resident with a Pennsylvania EBT ACCESS card can receive Abbott’s antigen coronavirus test, increasing COVID-19 testing across Pennsylvania. Continue Reading
By- Samantha McGrail
-
News
07 Jun 2021
6-in-1 Pediatric Vaccine from Merck, Sanofi Available Across US
The pediatric vaccine from Merck and Sanofi is the only hexavalent combination vaccine available in the US and is indicated for active immunization to help prevent six diseases. Continue Reading
By- Samantha McGrail
-
News
13 May 2021
Biogen, Capsigen Create AAV Capsids to Deliver Gene Therapies
The companies will utilize Capsigen’s TRADE platform and Biogen’s development and commercialization capabilities to deliver transformative gene therapies for certain disorders. Continue Reading
By- Samantha McGrail
-
News
05 May 2021
CVS Goes to Workplace Vaccination Sites to Boost Access
The pharmacy chain has partnered with over a dozen employers so far to operate workplace vaccination sites to boost access to COVID-19 vaccines. Continue Reading
By- Samantha McGrail
-
News
30 Apr 2021
AI in the Pharma Industry: Current Uses, Best Cases, Digital Future
Nearly 50% of global healthcare companies will implement artificial intelligence strategies and by 2025 and some experts believe it is crucial for how businesses operate down the line. Continue Reading
By- Samantha McGrail
-
News
29 Apr 2021
Abbott Launches Artificial Intelligence-Powered Imaging Platform
The artificial intelligence platform is an imaging software that leverages optical coherence tomography to help physicians’ decision-making during coronary stenting procedures. Continue Reading
By- Samantha McGrail
-
News
28 Apr 2021
FDA Completes Review of J&J Vaccine Manufacturing Facility
The vaccine manufacturing facility experienced a snafu earlier this year, meanwhile Sanofi has agreed to boost Moderna vaccine manufacturing. Continue Reading
By- Samantha McGrail
-
News
22 Apr 2021
Biogen Releases Update on Multiple Sclerosis Therapies Profile
The updates of the multiple sclerosis therapies include data on quality of life benefits and analyses of extended interval dosing with MS drug, Tysabri. Continue Reading
By- Samantha McGrail
-
News
20 Apr 2021
Eli Lilly Asks FDA to Revoke the EUA for COVID-19 Antibody Drug
In other COVID news, GSK and Vir Biotechnology said that the EMA has started a review for its COVID-19 antibody and Merck discontinued the development of its coronavirus treatment. Continue Reading
By- Samantha McGrail
-
News
13 Apr 2021
FDA, CDC Pauses J&J COVID-19 Vaccine Due To Rare Blood Clot Cases
Six cases of a rare and dangerous blood clot have been reported among women ages 18 to 48 who received the Johnson & Johnson COVID-19 vaccine. Continue Reading
By- Hannah Nelson, Assistant Editor
-
News
13 Apr 2021
Biotech Company Launches Medical Device for Blood Transfusions
The medical device for blood transfusions will improve the quality of life for patients who have received multiple transfusions and who suffer from hereditary or acquired diseases impacting red blood cells. Continue Reading
By- Samantha McGrail
-
News
08 Apr 2021
European Countries Suspend Use of AstraZeneca’s COVID-19 Vaccine
AstraZeneca’s COVID-19 vaccine may cause unusual blood clots with low blood platelets and should be listed as a rare side effect, the European Medicines Agency said. Continue Reading
By- Samantha McGrail
-
News
07 Apr 2021
AstraZeneca Eyes Medical Devices for Chronic Disease Management
MGH will utilize AstraZeneca’s chronic disease management platform to study heart failure and asthma management using real-world evidence. Continue Reading
By- Samantha McGrail
-
News
09 Mar 2021
CDC Advisors Recommend Johnson & Johnson COVID-19 Vaccine
CDC’s Advisory Committee on Immunization Practices has recommended the single-dose COVID-19 vaccine from Johnson & Johnson. Continue Reading
By- Samantha McGrail
-
News
03 Mar 2021
Additional Moderna Investments to Boost COVID-19 Vaccine Output
New capital investments will increase capacity at its owned and partnered manufacturing facilities, which will increase global output capacity of its COVID-19 vaccine. Continue Reading
By- Samantha McGrail
-
News
10 Feb 2021
Bristol Myers Squibb Gives $53M to Support Cancer Immunotherapies
The funds will be used to finance construction of the main building of the Center for Cancer Immunotherapy and Immunobiology in Japan. Continue Reading
By- Samantha McGrail
-
News
22 Jan 2021
COVID-19 Vaccine Dominates 2021 Pharmaceutical Industry Trends
The pharmaceutical industry’s response to the COVID-19 pandemic laid the groundwork for future industry trends both within the coronavirus battle and beyond. Continue Reading
By- Emily Sokol, MPH
-
News
15 Jan 2021
COVID-19, Vaccine Development Trends at JPM21
COVID-19 and other vaccine development efforts dominated conversation at this year’s J.P. Morgan Healthcare Conference. Continue Reading
By- Samantha McGrail
-
News
02 Nov 2020
Epic’s Broad Pharmacy Development Increases But Gaps Remain
Gaps in Epic’s broad pharmacy development include inadequate in-scope medication reporting, incomplete data, and lackluster support after implementation, KLAS found. Continue Reading
By- Samantha McGrail
-
News
29 Oct 2020
Definitive Healthcare Makes Another Key Life Sciences Acquisition
Definitive Healthcare has acquired Monocl with an eye on meeting the medical affairs needs of life sciences companies. Continue Reading
By- Kyle Murphy, PhD, Vice President of Editorial
-
News
16 Oct 2020
10 of the Largest Pharmaceutical Companies by Revenue
The top ten pharmaceutical companies with the highest revenue from Q1 and Q2 of 2020 include Johnson & Johnson, Roche, Sinopharm, Bayer, and Pfizer. Continue Reading
By- Samantha McGrail
-
News
27 May 2020
COVID-19 May Negatively Impact the Biopharmaceutical Industry
The COVID-19 pandemic will cause some biopharmaceutical companies to emerge weaker, dealing with delays in new product launches and with fewer resources to invest in R&D. Continue Reading
By- Samantha McGrail
-
News
14 May 2020
Cybersecurity Best Practices for the Pharma Sector Amid COVID-19
The COVID-19 pandemic has seen a spate of cyberattacks on the health and pharma sectors. Employing cybersecurity best practices will prove crucial to protecting these valuable systems. Continue Reading
By- Jessica Davis
-
News
12 May 2020
Apple Awards $10M to Give Hospitals COVID-19 Testing Kits
The fund will allow COPAN Diagnostics to rapidly accelerate its COVID-19 testing kit supply for hospitals across the US, which have been vital during the pandemic. Continue Reading
By- Samantha McGrail
-
News
22 Apr 2020
BARDA Director Rick Bright Leaves Agency Amid COVID-19 Pandemic
HHS replaces Rick Bright, director of BARDA since 2016, moving him to a new public-private partnership under NIH that will oversee COVID-19 testing platforms. Continue Reading
By- Samantha McGrail
-
News
17 Apr 2020
CRISPR Technology Detects COVID-19 From Respiratory RNA Extracts
New CRISPR- technology detects COVID-19 from respiratory RNA extracts, enabling point-of-care testing outside of the clinical diagnostic laboratory. Continue Reading
By- Samantha McGrail
-
News
30 Mar 2020
FDA Approves Prescription Digital Therapeutic for Chronic Insomnia
Pear Therapeutics receives FDA support for its prescription digital therapeutic that delivers digital cognitive behavioral therapy to chronic insomnia patients. Continue Reading
By- Samantha McGrail
-
News
19 Mar 2020
FDA Approves Roche’s Biomarker Test for At-Risk HPV Infections
The FDA recently approved Roche’s biomarker test, CINtec PLUS Cytology, to simplify decision making and ensure at-risk women receive vital health information. Continue Reading
By- Samantha McGrail
-
News
22 Jan 2020
Eli Lilly Snags $470M for NC Drug Manufacturing Plant
With a $470 million grant, Eli Lilly will open its first manufacturing facility in North Carolina. Continue Reading
By- Ana Mulero
-
News
14 Jan 2020
Definitive Healthcare Acquires PatientFinder, Eyes Life Sciences
The addition of PatientFinder analytics will speed the identification of patient cohorts to improve product development in the life sciences. Continue Reading
By- Kyle Murphy, PhD, Vice President of Editorial
-
News
04 Dec 2019
250K Docs Using Drug Price Transparency Tools, Benefits Checkers
Drug price transparency tools help address high patient costs, medication adherence, and care access. Continue Reading
By- Sara Heath, Executive Editor
-
News
22 Nov 2019
Data Analytics Key in 2020 Pharmaceutical Industry Predictions
The future of healthcare is increasingly digital, and the pharmaceutical industry is no exception. Continue Reading
By- Sara Heath, Executive Editor